The location of KIT and PDGFRA gene mutations in gastrointestinal stromal tumours is site and phenotype associated

作者: R Penzel

DOI: 10.1136/JCP.2004.021766

关键词:

摘要: Aims: To assess the relation between KIT and PDGFRA mutations site of origin, histological phenotype, pathomorphologically determined risk assessment in gastrointestinal stromal tumours (GISTs). Methods: A series 83 clinicopathologically characterised GISTs from 79 patients was analysed for by polymerase chain reaction amplification, single strand conformation polymorphism analysis, direct DNA sequencing. Results: or were found 57 11 GISTs, respectively. Most involved exon (46 cases), followed 9 (10 cases). The mostly affected 18 (eight 12 (three There a significant association an intestinal origin gastric tumours. In addition, presence significantly associated with epithelioid/mixed histology, as absence identified receptor tyrosine kinase mutations. Vice versa, almost exclusively spindle cell GISTs. Furthermore, any alone high risk/malignant Conclusions: location is phenotype. Genotyping may be helpful additional parameter determining biological profile these

参考文章(34)
Allan T van Oosterom, Ian Judson, Jaap Verweij, Sigrid Stroobants, Eugenio Donato di Paola, Sasa Dimitrijevic, Marc Martens, Andrew Webb, Raf Sciot, Martine Van Glabbeke, Sandra Silberman, Ole S Nielsen, Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours: a phase I study. The Lancet. ,vol. 358, pp. 1421- 1423 ,(2001) , 10.1016/S0140-6736(01)06535-7
Theresa S. Emory, Leslie H. Sobin, Laura Lukes, Dong H. Lee, Timothy J. O'Leary, Prognosis of gastrointestinal smooth-muscle (stromal) tumors: dependence on anatomic site. The American Journal of Surgical Pathology. ,vol. 23, pp. 82- 87 ,(1999) , 10.1097/00000478-199901000-00009
Agnès Chompret, Caroline Kannengiesser, Michel Barrois, Philippe Terrier, Philippe Dahan, Thomas Tursz, Gilbert M. Lenoir, Brigitte Bressac-De Paillerets, PDGFRA germline mutation in a family with multiple cases of gastrointestinal stromal tumor Gastroenterology. ,vol. 126, pp. 318- 321 ,(2004) , 10.1053/J.GASTRO.2003.10.079
Michael C. Heinrich, Brian P. Rubin, B.Jack Longley, Jonathan A. Fletcher, Biology and genetic aspects of gastrointestinal stromal tumors: KIT activation and cytogenetic alterations Human Pathology. ,vol. 33, pp. 484- 495 ,(2002) , 10.1053/HUPA.2002.124124
Christopher D.M. Fletcher, Jules J. Berman, Christopher Corless, Fred Gorstein, Jerzy Lasota, B.Jack Longley, Markku Miettinen, Timothy J. O'Leary, Helen Remotti, Brian P. Rubin, Barry Shmookler, Leslie H. Sobin, Sharon W. Weiss, Diagnosis of gastrointestinal stromal tumors: A consensus approach Human Pathology. ,vol. 33, pp. 459- 465 ,(2002) , 10.1053/HUPA.2002.123545
Christopher D.M. Fletcher, Heikki Joensuu, George D. Demetri, Margaret von Mehren, Charles D. Blanke, Annick D. Van den Abbeele, Burton Eisenberg, Peter J. Roberts, Michael C. Heinrich, David A. Tuveson, Samuel Singer, Milos Janicek, Jonathan A. Fletcher, Stuart G. Silverman, Sandra L. Silberman, Renaud Capdeville, Beate Kiese, Bin Peng, Sasa Dimitrijevic, Brian J. Druker, Christopher Corless, Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. The New England Journal of Medicine. ,vol. 347, pp. 472- 480 ,(2002) , 10.1056/NEJMOA020461
Eva Wardelmann, Iris Neidt, Erhard Bierhoff, Nicola Speidel, Christoph Manegold, Hans-Peter Fischer, Ulrich Pfeifer, Torsten Pietsch, c-kit Mutations in Gastrointestinal Stromal Tumors Occur Preferentially in the Spindle Rather Than in the Epithelioid Cell Variant Modern Pathology. ,vol. 15, pp. 125- 136 ,(2002) , 10.1038/MODPATHOL.3880504
Markku Miettinen, Wa'El El-Rifai, Leslie H, Jerzy Lasota, Evaluation of malignancy and prognosis of gastrointestinal stromal tumors: A review Human Pathology. ,vol. 33, pp. 478- 483 ,(2002) , 10.1053/HUPA.2002.124123
Eva Wardelmann, Inge Losen, Volkmar Hans, Iris Neidt, Nicola Speidel, Erhard Bierhoff, Thomas Heinicke, Torsten Pietsch, Reinhard Büttner, Sabine Merkelbach-Bruse, Deletion of Trp-557 and Lys-558 in the juxtamembrane domain of the c-kit protooncogene is associated with metastatic behavior of gastrointestinal stromal tumors. International Journal of Cancer. ,vol. 106, pp. 887- 895 ,(2003) , 10.1002/IJC.11323
David A. Tuveson, George D. Demetri, Anette Duensing, Sheng Xiao, Brian P. Rubin, Christopher D. M. Fletcher, Connie Tsao, Marcia L. Lux, Michele K. Hibbard, Samuel Singer, Jonathan A. Fletcher, Robert Ruiz, Chang-Jie Chen, KIT activation is a ubiquitous feature of gastrointestinal stromal tumors. Cancer Research. ,vol. 61, pp. 8118- 8121 ,(2001)